News
07-21-2009, 04:15 AM
An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer. Some scientists suspected that tamoxifen has antifungal properties; now new research from the University of Rochester Medical Center shows that it actually kills fungus cells and stops them from causing disease.
More... (http://www.medicalnewstoday.com/articles/158153.php)
More... (http://www.medicalnewstoday.com/articles/158153.php)